Description
Report Code: PHP11677. April, 2011. Montreal, QC
ARTICLE I
Global Opportunities for Canadian Life Sciences
Krista Robinson
Senior Manager, Tax Services
Ernst & Young LLP
Elizabeth Pringle, M.Sc.
Senior Manger, SR&ED Tax Credit Practice
Ernst &Young LLP
ARTICLE II
Quality Speed Access
Karen Arts, BSN, RN, CCRC
Director, Business Development
Ontario Institute for Cancer Research
Chair, Network of Networks
ARTICLE III
Considerations for Successful Outsourcing Partnerships
Joanne E. Watson, MSc
President and Chief Executive Officer
Integrated Research Inc.
ARTICLE IV
Quality Management Approach to Better Research
Marianne Vanderwel
Director, Human Research Protection Program
Institutional Review Board Services
ARTICLE V
Laying the Bedrock of the Clinical Trial Framework – Negotiation and Early Stage Best Practices
Tracey Allin, BScN, RN
Regional Research Manager, Clinical Operations
Eli Lilly Canada, Inc.
ARTICLE VI
Laying the Bedrock of the Clinical Trial Framework
Olga Farman
Associate
Lavery de Billy LLP
ARTICLE VII
Laying the Bedrock of the Clinical Trial Framework
Michelle Moldofsky, LLB, LLM
Policy and Legal Adviser, Office of Research Administration
St. Michael’s Hospital
ARTICLE VIII
The Patient Perspective and Patient Interests in Clinical Trials – Aligning Best Interests
Nadine Prévost
Director, Client Services and Social Action (Quebec Division)
Multiple Sclerosis Society of Canada
Hana Salaheddine
Multiple Sclerosis Patient Representative
Multiple Sclerosis Society of Canada
ARTICLE IX
Clinical Research: The Doctor and her Patient
Pierre Geoffroy, MD, CM, MSc, FCFP
Chief Medical Officer
Lambda Canada
ARTICLE X
Budget Negotiations and Budget Templates – Getting Down to Brass Tacks
Jean Langlais, Ph.D.
Director, Office of Research Agreements
Centre hospitalier universitaire Sainte-Justine
ARTICLE XI
Using Information Technology to Facilitate Successful Clinical Trials and Manage Privacy
Darran Boyer, MAcc
President
Independent Data Integrator
ARTICLE XII
Using Information Technology to Facilitate Successful Clinical Trials and Manage Privacy
Rady Khuong
Partner
Stein Monast LLP
ARTICLE XIII
Maximizing International Opportunities in Clinical Trials – A Global Review of Clinical Site Selection
Fabio A. Thiers, MD, MSc, PhD
CEO – ViS Research Institute
Director, Global Clinical Trials Research Program
Massachusetts Institute of Technology and National Bureau of Economic Research (NBER)
ARTICLE XIV
RESPONDENT Clinical Research : The Doctor and her Patient
Pierre Geoffroy, MD, CM, MSc, FCFP
Chief Medical Officer
Lambda Canada
ARTICLE XV
Using the Web to Facilitate Patient Participation in Clinical Trials
Sandra Gazel, MSc
Associate Director, Clinical Operations
Abbott Laboratories Canada
Sima Chiva-Razavi
Clinical Research Interim
Abbott Laboratories Canada
ARTICLE XVI
Legal, Ethical and Regulatory Compliance – Getting to Good (and Knowing When It is Good Enough)
Franca Cantini, MScN
Chief, Research Ethics Office
Jewish General Hospital
Felicia Tiseo
Research Ethics Quality Assurance Coordinator
Jewish General Hospital
Marie-Luce Fortier, LL.L, LL.B
Senior Manager, Development of Contractual Research
Centre Hospitalier de l’Université de Montréal (CHUM)
ARTICLE XVII
Canada Inspectorate: Protection of Participants, Quality of Processes..and Competitiveness?
Pierre Gervais, B.Pharm., L.Pharm., MSc
President, Executive Director
Q&T Research Sherbrooke Inc.
ARTICLE XVIII
Investigator-initiated Clinical Research: A Network to Discover Biomarkers through Biopsy-driven Clinical Research
Dr. Gerald Batist
Director of Segal Cancer Centre
Jewish General Hospital
ARTICLE XIX
Investigator Initiated Trials – Untangling that Tangled Web
P. Bradley Limpert
Partner, Patent and Trade Mark Agent
Cameron Mackendrick LLP
ARTICLE XX
Mastering IP and Related Legal Issues Through Effective Clinical Trial Agreements
Andrew Loh
Partner
Borden Ladner Gervais LLP
Beverley Moore
Associate
Borden Ladner Gervais LLP